NIAID DIVISION OF ALLERGY, IMMUNOLOGY&TRANSPLANTATION: IMMUNE MEDIATED DISEASES CLINICAL PRODUCTS CENTER (CPC)

根据合同，临床产品中心为所有DAIT资助和/或申办的临床研究项目以及其他NIAID资助的临床试验提供研究产品服务。支持的研究涵盖广泛的免疫介导的疾病和罕见疾病，包括：（一）哮喘和过敏性疾病;（二）自身免疫性疾病;（三）实体器官，组织和细胞移植中的免疫介导的排斥反应;以及（四）基础科学研究（阿片类疫苗研究）。此外，根据需要，还进行传染病治疗（即SARS-CoV-2）、预防和其他疫苗研究的临床试验。待研究的试验用药品包括表I至表VI药物制剂、生物制剂、作为研究干预的食品和其他制剂。

The Clinical Product Center under contract, provides Investigational Product Services for all DAIT-funded and/or sponsored clinical research programs and other NIAID-funded clinical trials as needed. Studies to be supported encompass a broad range of immune-mediated & rare diseases, including: (i) asthma and allergic diseases; (ii) autoimmune disorders; (iii) immune-mediated rejection in solid organ, tissue and cell transplantation; and (iv) (v) Basic Science studies (Opioid Vaccine studies). Additionally, and on an as-needed basis, clinical trials of infectious disease treatment (i.e.SARS-CoV-2), prevention and other vaccine studies. Investigational Products to be studied include schedule I through VI pharmaceutical agents, biologics, foods as study interventions, and other agents.